StockData

Yubo International Biotech Ltd (YBGJ) shareholders

YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.01+0.00 (0.00%)

Close on Oct 16, 2026Market cap $886.19KP/E –Yield –

Ownership

Who owns Yubo International Biotech's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Jun Wang
Joint filing with Flydragon International Ltd (48.10%)
81,943,80048.10%13D (active) amendmentJul 23, 2025
Chinaone Technology Ltd
Joint filing with Yang Wang (15.10%)
25,811,40015.10%13D (active) amendmentJul 23, 2025
Boao Biotech Ltd
Joint filing with Cao Yulin (16.60%)
19,927,66016.60%13G (passive)Jan 25, 2024

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Yang WangChief Executive Officer, Director, 10% owner25,811,40015.15%Jul 25, 2025
Jun WangPresident, Director, 10% owner81,943,80048.08%Jul 25, 2025
Nanping HuDirector0–May 5, 2025
Biotech Ltd Boao10% owner24,967,80014.65%Jun 3, 2025
Yulin Cao10% owner19,927,66011.69%Jun 3, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Yang Wang
Chief Executive Officer, Director, 10% owner
Jul 23, 2025Award+8,600,000$0.05$430.00K25,811,400
Jun Wang
President, Director, 10% owner
Jul 23, 2025Award+42,000,000$0.05$2.10M81,943,800
Yang Wang
Chief Executive Officer, Director, 10% owner
Jul 15, 2024Sale−2,000,000$0.12$240.00K17,211,400
Yulin Cao
10% owner
Jan 25, 2024Sale−380,174$0.30$114.05K19,927,660
Yulin Cao
10% owner
Jan 25, 2024Sale−301,701$0.30$90.51K23,424,578
Yulin Cao
10% owner
Jan 25, 2024Sale−741,521$0.30$222.46K23,726,279
Yulin Cao
10% owner
Jan 25, 2024Sale−500,000$0.30$150.00K24,467,800
Yulin Cao
10% owner
Jan 25, 2024Sale−364,351$0.30$109.31K23,060,227
Yulin Cao
10% owner
Jan 25, 2024Sale−2,057,586$0.30$617.28K20,307,834
Yulin Cao
10% owner
Jan 25, 2024Sale−426,654$0.30$128.00K22,365,420
Yulin Cao
10% owner
Jan 25, 2024Sale−86,897$0.30$26.07K22,792,074
Yulin Cao
10% owner
Jan 25, 2024Sale−181,256$0.30$54.38K22,878,971
Lina Liu
Chief Financial Officer
Nov 9, 2022Sale−4,728,000$0.50$2.36M9,101,400
Draw Group Ltd Focus
–
Sep 23, 2022Sale−4,728,000$0.50$2.36M9,101,400
Jun Wang
President and CEO, Director, 10% owner
Jan 14, 2021Buy+39,943,800––39,943,800
Lina Liu
CFO, Treasurer and Secretary
Jan 14, 2021Buy+13,829,400––13,829,400
Lina Liu
CFO, Treasurer and Secretary
Jan 14, 2021Returned to company−116,697,438––0
Yang Wang
Director, 10% owner
Jan 14, 2021Buy+19,211,400––19,211,400
Jonathan Adereth
Director
Oct 31, 2005Award+208,620$8000.00$1.67B208,620
Seymour Kessler
Director
Oct 31, 2005Award+142,035$5417.00$769.40M142,035

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
0.0%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Yubo International Biotech's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

See a number that looks wrong?